1-2 of 2
Gabriela Forestieri
Close
Sort by
Journal Articles

SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma

Clinical Trials & Observations
Anastasios Stathis, Ulrich Mey, Sämi Schär, Felicitas Hitz, Christiane Pott, Nicolas Mach, Fatime Krasniqi, Urban Novak, Christian Schmidt, Karin Hohloch, Dirk Lars Kienle, Dagmar Hess, Alden A. Moccia, Michael Unterhalt, Katrin Eckhardt, Stefanie Hayoz, Gabriela Forestieri, Davide Rossi, Stefan Dirnhofer, Luca Ceriani, Giulio Sartori, Francesco Bertoni, Christian Buske, Emanuele Zucca, Wolfgang Hiddemann
Journal: Blood Advances
Blood Adv (2022) 6 (13): 3911–3920.
https://doi.org/10.1182/bloodadvances.2021006520
Published: 2022
Includes: Supplemental data
Journal Articles

Circulating tumor DNA for comprehensive noninvasive monitoring of lymphoma treated with ibrutinib plus nivolumab

Alessio Bruscaggin, Lodovico Terzi di Bergamo, Valeria Spina, Brendan Hodkinson, Gabriela Forestieri, Ferdinando Bonfiglio, Adalgisa Condoluci, Wei Wu, Maria C. Pirosa, Martin R. Faderl, Ricardo Koch, Michael Schaffer, John D. Alvarez, Nele Fourneau, Bernhard Gerber, Georg Stussi, Emanuele Zucca, Sriram Balasubramanian, Davide Rossi
Journal: Blood Advances
Blood Adv (2021) 5 (22): 4674–4685.
https://doi.org/10.1182/bloodadvances.2021004528
Published: 2021
Includes: Supplemental data